Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,730 across all filing types
Latest filing 2024-09-05 Capital/Financing Update
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
本公司董事會通過以子公司向SANOFI VIETNAM SHAREHOLDING COMPANY購買Alpha Choay越南藥證
Capital/Financing Update Classification · 95% confidence The document is a regulatory announcement from a listed company (1795 美時) disclosing a board resolution approving a transaction by its subsidiary to purchase intellectual property and drug licenses from SANOFI VIETNAM SHAREHOLDING COMPANY. The content includes detailed transaction terms, dates, parties involved, and accounting firm information. It is a formal disclosure of a capital/asset transaction rather than a full financial report or earnings release. The document length is short (1905 characters) and it is not a report publication announcement or certification. The nature of the content fits best with a Capital/Financing Update (CAP) as it relates to a significant asset acquisition and capital use. Therefore, the appropriate classification is CAP with high confidence.
2024-09-05 Chinese
代重要子公司Alvogen Korea Holdings Ltd.公告 召開股東臨時會
Board/Management Information Classification · 95% confidence The document is a short announcement (740 characters) from a company (1795 美時) regarding the convening of an extraordinary shareholders meeting for its important subsidiary Alvogen Korea Holdings Ltd. It includes details such as the board resolution date, meeting date, location, and agenda items, specifically the election of directors. There are no financial statements or detailed reports included. The document is an announcement about a meeting and its agenda, not a report or detailed filing. It fits best under Board/Management Information (MANG) as it relates to the election of directors and management changes.
2024-09-03 Chinese
代重要子公司Lotus International Pte. Ltd.公告董事當選名單
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the election results of a director at a subsidiary company, Lotus International Pte. Ltd. It details the change in board membership, including the name of the director, the reason for change (term expiration), and other related information. There is no financial data, report, or presentation content. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2024-08-27 Chinese
代重要子公司Lotus International Pte. Ltd.公告 股東臨時會重要決議事項
Board/Management Information Classification · 95% confidence The document is a brief announcement from a company (1795 美時) regarding an important resolution made at a shareholders' extraordinary meeting of its subsidiary Lotus International Pte. Ltd. The key content is the election of the company's directors. The document is short (503 characters) and serves as a notification of a corporate governance event rather than a detailed report or financial statement. It does not contain financial data, audit information, or detailed management discussion. It specifically relates to board matters (election of directors). Therefore, the most appropriate classification is Board/Management Information (MANG).
2024-08-27 Chinese
代重要子公司Lotus International Pte. Ltd.公告 召開股東臨時會
Regulatory Filings Classification · 95% confidence The document is a brief announcement from a company (1795 美時) regarding the convening of an extraordinary shareholders' meeting for its important subsidiary Lotus International Pte. Ltd. The announcement includes details such as the date of the board resolution, the date and location of the shareholders' meeting, and the agenda items including approval of the 2023 financial report, election of directors, and appointment of auditors. The document is short (704 characters) and serves as a notification of the meeting and its agenda rather than the full financial report or detailed meeting materials. It does not contain actual financial statements or detailed analysis, nor is it a transcript or voting result. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about the meeting and agenda.
2024-08-27 Chinese
公告本公司法人董事代表人異動
Board/Management Information Classification · 100% confidence The document is a short announcement about a change in the company's board representative, specifically the appointment of a new legal entity director representative. It includes details such as the name of the new representative, their background, and the effective date. There is no financial data, no mention of financial results, reports, or regulatory filings beyond this management change. The document length is only 658 characters, indicating it is a brief announcement. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2024-08-21 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.